Professional Documents
Culture Documents
RATNAWATI
DEPARTMENT OF PULMONOLOGY AND RESPIRATORY
MEDICINE, FACULTY OF MEDICINE
UNIVERSITY OF INDONESIA
PERSAHABATAN HOSPITAL
JAKARTA
Introduction
Bellows spirometers:
Measure volume; mainly in lung function
units
Electronic desk top spirometers:
Measure flow and volume with real time
display
Small hand-held spirometers:
Inexpensive and quick to use but no
print out
Small Hand-held Spirometers
Measurements
Flow Volume
The flow-volume curve
The F-V curve was
peak flow
invented to make
the recognition of
spirometry patterns
easier.
• You can’t
FVC measure the FEV1
from F-V curves.
Early stop
G t!
Great!
Poor effort
Hesitant
Start
Acceptable and Unacceptable
Spirograms (from ATS, 1994)
cALIBRATION
Phase 2 Phase 3
Blast out! Keep blowing
End
Phase 1
Inhale deeply Start
Good test session
1. Obtain 3 acceptable maneuvers
Look at graphs individually to make sure there
are no errors on at least 3
Fixed tresholds:
FVC %Predicted < 80%
FEV1 %Predicted < 80%
Observed FEV1/FVC% < 75%
Spirogram Patterns
Normal
Obstructive
Restrictive
Affected by:
Age
Height
Sex
Ethnic Origin
Normal Trace Showing FEV1 and FVC
5 FVC
Volume, liters
4
FEV1 = 4L
3
FVC = 5L
2
FEV1/FVC = 0.8
1
1 2 3 4 5 6
Time, sec
Criteria for Normal
Post-bronchodilator Spirometry
* Some guidelines suggest nebulised bronchodilators can be given but the doses
are not standardised. “There is no consensus on the drug, dose or mode of
administering a bronchodilator in the laboratory.” Ref: ATS/ERS Task Force :
Interpretive strategies for Lung Function Tests ERJ 2005;26:948
** Usually 8 puffs of 20 µg
Measurements
Definition of reversibility
Pre-Bronchodilator
- FEV1/FVC <70% of predicted
Post-Bronchodilator
- Increase 12% AND at least 200 cc
Reversibility = Asthma!
Measurements
Severity of obstruction
FEV1 % of predicted
Mild >80
Moderate 50 to 79
Severe 30 to
Very severe <30
Severity of restriction
FVC % of predicted
Mild >65 to 80
Moderate >50 to 65
Severe <50
SPIROMETRY
OBSTRUCTIVE
DISEASE
Spirometry: Obstructive Disease
5 Normal
Volume, liters
3
FEV1 = 1.8L
2
FVC = 3.2L Obstructive
1
FEV1/FVC = 0.56
1 2 3 4 5 6
Time, seconds
Obstructive Airway Disease
Obstruction
FEV1 < 80%
predicted
FEV1/FVC < 75%
Spirometric Diagnosis of COPD
Post-bronchodilator FEV1/FVC
measured 15 minutes after 400µg
salbutamol or equivalent
Bronchodilator Reversibility Testing
in COPD
Preparation
•Tests should be performed when patients are clinically stable
and free from respiratory infection
• Patients should not have taken:
inhaled short-acting bronchodilators in the previous six
hours
long-acting bronchodilator in the previous 12 hours
sustained-release theophylline in the previous 24 hours
Bronchodilator Reversibility Testing
in COPD
Results
•An increase in FEV1 that is both greater than 200 ml
and 12% above the pre-bronchodilator FEV1 (baseline
value) is considered significant
RESTRICTIVE
DISEASE
Criteria: Restrictive Disease
Normal
5
Volume, liters
3
Restrictive
FEV1 = 1.9L
2
FVC = 2.0L
1
FEV1/FVC = 0.95
1 2 3 4 5 6
Time, seconds
Mixed Obstructive/Restrictive
Normal
Volume, liters
FEV1 = 0.5L
Obstructive - Restrictive FVC = 1.5L
FEV1/FVC = 0.30
Time, seconds
Restrictive and mixed obstructive-restrictive are difficult to diagnose by spirometry alone; full
respiratory function tests are usually required (e.g., body plethysmography, etc)
Normal vs. Obstructive vs.
Restrictive
(Hyatt, 2003)
Unacceptable spirometry
FEV1/FVC
<LLN Normal
FEV1 FVC
Identify presence or
absence of obstruction
Assess Vital Capacity
Grade severity of
obstruction or restriction
Assess gas exchange
abnormality
Consider other factors:
Performance
Chest wall or
neuromuscular
Central airways
PROJEct PNEUMOBILE INDONESIA